₹1,148.1
▲ +0.3%
31 Jul
Dr Reddy's Laboratories is a leading Indian pharmaceutical company engaged in the discovery, development, manufacturing, and marketing of generic drugs, active pharmaceutical ingredients, and specialty pharmaceuticals. The company operates across multiple therapeutic segments including cardiovascular, gastroenterology, diabetes, oncology, and respiratory, serving domestic and international markets. Dr Reddy's maintains a significant presence in India's pharmaceutical sector through its strong portfolio of branded generics, over-the-counter products, and active pharmaceutical ingredient manufacturing capabilities.
● hover near green dot for dividend
| Period | Revenue (cr) | Expenses (cr) | Op. Profit (cr) | Other Inc. (cr) | Interest (cr) | Dep. (cr) | PBT (cr) | Net Profit (cr) | EPS |
|---|---|---|---|---|---|---|---|---|---|
| Jun 2026 | 8,100 | 6,885 | 860 | 355 | 126 | 537 | 553 | 436 | ₹5.33 |
| Mar 2026 | 7,546 | 6,689 | 383 | 475 | 106 | 557 | 195 | 221 | ₹2.65 |
| Dec 2025 | 8,753 | 6,597 | 1,888 | 269 | 94.40 | 521 | 1,541 | 1,190 | ₹14.53 |
| Sep 2025 | 8,828 | 6,495 | 2,010 | 324 | 90.70 | 505 | 1,739 | 1,337 | ₹16.18 |
| Jun 2025 | 8,572 | 6,108 | 2,174 | 290 | 83.00 | 476 | 1,905 | 1,410 | ₹17.04 |
| Mar 2025 | 8,528 | 6,008 | 1,998 | 522 | 65.60 | 455 | 2,000 | 1,587 | ₹19.12 |
| Dec 2024 | 8,381 | 5,954 | 2,273 | 154 | 82.00 | 471 | 1,874 | 1,404 | ₹16.94 |
| Sep 2024 | 8,038 | 5,648 | 2,076 | 314 | 76.00 | 397 | 1,917 | 1,342 | ₹15.05 |
| Jun 2024 | 7,696 | 5,372 | 2,131 | 193 | 60.00 | 381 | 1,883 | 1,392 | ₹16.69 |
| Mar 2024 | 7,114 | 5,082 | 1,831 | 201 | 59.00 | 368 | 1,605 | 1,310 | ₹15.70 |
| Dec 2023 | 7,237 | 4,995 | 2,023 | 219 | 39.00 | 374 | 1,829 | 1,381 | ₹16.56 |
| Sep 2023 | 6,903 | 4,575 | 2,009 | 319 | 35.00 | 376 | 1,917 | 1,482 | ₹17.77 |
| Jun 2023 | 6,758 | 4,518 | 2,062 | 178 | 37.00 | 353 | 1,850 | 1,405 | ₹16.87 |
| Mar 2023 | 6,315 | 4,635 | 1,534 | 146 | 35.00 | 316 | 1,329 | 960 | ₹11.53 |
| Dec 2022 | 7,237 | — | 2,023 | — | — | — | — | 1,381 | ₹16.56 |
| Sep 2022 | 6,903 | — | 2,008 | — | — | — | — | 1,482 | ₹17.77 |
| Jun 2022 | 6,758 | — | 2,062 | — | — | — | — | 1,405 | ₹16.87 |
| Period | Total Assets (cr) | Total Equity (cr) | Total Debt (cr) | D/E |
|---|---|---|---|---|
| Mar 2026 | 58,123 | 37,892 | 7,557 | 0.20 |
| Mar 2025 | 49,427 | 33,550 | 4,185 | 0.12 |
| Mar 2024 | 38,780 | 28,254 | — | — |
| Mar 2023 | 32,209 | 23,286 | — | — |
| Period | Operating (cr) | Investing (cr) | Financing (cr) | Net Cash (cr) | Free Cash Flow (cr) |
|---|---|---|---|---|---|
| Mar 2026 | 5,674 | -6,549 | 829 | -46.60 | 2,004 |
| Mar 2025 | 4,643 | -5,102 | 1,186 | 726 | 1,254 |
